Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 2
1965 1
1967 1
1973 1
1974 1
1975 1
1976 1
1979 1
1982 1
1985 2
1987 2
1988 1
1989 2
1990 5
1991 3
1994 2
1995 2
1996 3
1997 3
1998 1
1999 5
2000 6
2001 7
2002 8
2003 3
2004 15
2005 21
2006 14
2007 26
2008 14
2009 28
2010 24
2011 34
2012 52
2013 57
2014 58
2015 73
2016 78
2017 85
2018 106
2019 100
2020 119
2021 117
2022 72
Text availability
Article attribute
Article type
Publication date

Search Results

1,023 results
Results by year
Filters applied: . Clear all
Page 1
A safe and potent anti-CD19 CAR T cell therapy.
Ying Z, Huang XF, Xiang X, Liu Y, Kang X, Song Y, Guo X, Liu H, Ding N, Zhang T, Duan P, Lin Y, Zheng W, Wang X, Lin N, Tu M, Xie Y, Zhang C, Liu W, Deng L, Gao S, Ping L, Wang X, Zhou N, Zhang J, Wang Y, Lin S, Mamuti M, Yu X, Fang L, Wang S, Song H, Wang G, Jones L, Zhu J, Chen SY. Ying Z, et al. Among authors: tu m. Nat Med. 2019 Jun;25(6):947-953. doi: 10.1038/s41591-019-0421-7. Epub 2019 Apr 22. Nat Med. 2019. PMID: 31011207 Free PMC article. Clinical Trial.
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.
Tu MM, Lee FYF, Jones RT, Kimball AK, Saravia E, Graziano RF, Coleman B, Menard K, Yan J, Michaud E, Chang H, Abdel-Hafiz HA, Rozhok AI, Duex JE, Agarwal N, Chauca-Diaz A, Johnson LK, Ng TL, Cambier JC, Clambey ET, Costello JC, Korman AJ, Theodorescu D. Tu MM, et al. Sci Adv. 2019 Feb 20;5(2):eaav2437. doi: 10.1126/sciadv.aav2437. eCollection 2019 Feb. Sci Adv. 2019. PMID: 30801016 Free PMC article.
Clinical validity of saliva and novel technology for cancer detection.
Kaczor-Urbanowicz KE, Wei F, Rao SL, Kim J, Shin H, Cheng J, Tu M, Wong DTW, Kim Y. Kaczor-Urbanowicz KE, et al. Among authors: tu m. Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):49-59. doi: 10.1016/j.bbcan.2019.05.007. Epub 2019 May 30. Biochim Biophys Acta Rev Cancer. 2019. PMID: 31152821 Free PMC article. Review.
Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry.
Writing Group for the BASILAR Group, Zi W, Qiu Z, Wu D, Li F, Liu H, Liu W, Huang W, Shi Z, Bai Y, Liu Z, Wang L, Yang S, Pu J, Wen C, Wang S, Zhu Q, Chen W, Yin C, Lin M, Qi L, Zhong Y, Wang Z, Wu W, Chen H, Yao X, Xiong F, Zeng G, Zhou Z, Wu Z, Wan Y, Peng H, Li B, Hu X, Wen H, Zhong W, Wang L, Jin P, Guo F, Han J, Fu X, Ai Z, Tian X, Feng X, Sun B, Huang Z, Li W, Zhou P, Tu M, Sun X, Li H, He W, Qiu T, Yuan Z, Yue C, Yang J, Luo W, Gong Z, Shuai J, Nogueira RG, Yang Q. Writing Group for the BASILAR Group, et al. Among authors: tu m. JAMA Neurol. 2020 May 1;77(5):561-573. doi: 10.1001/jamaneurol.2020.0156. JAMA Neurol. 2020. PMID: 32080711 Free PMC article.
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.
Wang Y, Jiang T, Qin Z, Jiang J, Wang Q, Yang S, Rivard C, Gao G, Ng TL, Tu MM, Yu H, Ji H, Zhou C, Ren S, Zhang J, Bunn P, Doebele RC, Camidge DR, Hirsch FR. Wang Y, et al. Among authors: tu mm. Ann Oncol. 2019 Mar 1;30(3):447-455. doi: 10.1093/annonc/mdy542. Ann Oncol. 2019. PMID: 30596880 Free PMC article. Clinical Trial.
1,023 results